The Primary
Care Companionfor CNS Disorders

Schizophrenia/Schizoaffective Disorders

Brief Report December 15, 2005

Brief Report: Aripiprazole for the Treatment of Tourette's Disorder

Prasad R. Padala; S. Faiz Qadri; Vishal Madaan

Prim Care Companion J Clin Psychiatry 2005;7(6):296-299

Article Abstract

Brief Report: Aripiprazole for the Treatment of Tourette’s Disorder

Download Free PDF

This PDF is free for all visitors!

Save

Cite

INFORMATION FROM INDUSTRY

AUVELITY is an FDA-approved treatment for adults with MDD. Auvelity, is a rapid-acting antidepressant with a multimodal mechanism, targeting both glutamatergic and monoaminergic pathways. Learn more about how AUVELITY is thought to work and side effects. Please see Important Safety Information within this document and the full Prescribing Information.

Vol 26 • 2024 • Number 6

Read the Current Issue

Narrative Review

Dextromethorphan-Quinidine for Agitation in Dementia

Original Research

Psychiatric Comorbidities in Adolescents With Polycystic Ovary Syndrome

Original Research

Intervention to Enhance Mental Health Competency

Original Research

Evolution of Treatment Modalities for PTSD

Rounds in the General Hospital

Etiology, Prevention, and Management of TD

Rounds in the General Hospital

Comorbid Bipolar Disorder and PTSD

View current Issue

Brief Report

Treatment Decision-Making Capacity With the MacCAT-T in Schizophrenia

June 1, 2023

This report is a narrative review of the studies on schizophrenia that evaluated both decision-making capacity for treatment with the MacCAT-T and severity of symptoms using a clinical rating...

Hirofumi Hirakawa

Brief Report

Omission of Amisulpride From the US Residency Training Curriculum

November 4, 2021

In this report, the author discusses the second-generation antipsychotic amisulpride, which is used around the world for treatment of schizophrenia but is not approved for any mental health indication...

Mayank Gupta

Brief Report

Clozapine Is Associated With Higher COVID-19 Infection Rate in Veterans With Schizophrenia

August 24, 2021

Does clozapine treatment increase the odds of testing positive for COVID-19? This small study of a VA patient population posed the question.

Olaoluwa O. Okusaga, Brian G. Mitchell, Jared D. Bernard, et al

Brief Report: Aripiprazole for the Treatment of Tourette's Disorder

Read the Current Issue

Dextromethorphan-Quinidine for Agitation in Dementia

Psychiatric Comorbidities in Adolescents With Polycystic Ovary Syndrome

Intervention to Enhance Mental Health Competency

Evolution of Treatment Modalities for PTSD

Etiology, Prevention, and Management of TD

Comorbid Bipolar Disorder and PTSD

ELSEWHERE:

FOLLOW US:

Brief Report: Aripiprazole for the Treatment of Tourette's Disorder

Read the Current Issue

Dextromethorphan-Quinidine for Agitation in Dementia

Psychiatric Comorbidities in Adolescents With Polycystic Ovary Syndrome

Intervention to Enhance Mental Health Competency

Evolution of Treatment Modalities for PTSD

Etiology, Prevention, and Management of TD

Comorbid Bipolar Disorder and PTSD

Related Articles

Treatment Decision-Making Capacity With the MacCAT-T in Schizophrenia

Omission of Amisulpride From the US Residency Training Curriculum

Clozapine Is Associated With Higher COVID-19 Infection Rate in Veterans With Schizophrenia

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles